Workflow
BLOKS(00325)
icon
Search documents
布鲁可(00325) - 截至二零二五年七月三十一日止月份之股份发行人的证券变动月报表
2025-08-06 12:00
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 布魯可集團有限公司 呈交日期: 2025年8月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00325 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 500,000,000 | USD | | 0.0001 | USD | | 50,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 500,000,000 | USD | | 0.0001 | USD | | 50,000 | 本月底法定/註冊股本總額: USD 5 ...
VITASOY INT‘L(00325)8月1日斥资1689.01万港元回购184.4万股
智通财经网· 2025-08-01 10:07
智通财经APP讯,VITASOY INT'L(00325)发布公告,于2025年8月1日斥资1689.01万港元回购股份184.4 万股,每股回购价格为9.14-9.17港元。 ...
VITASOY INT‘L8月1日斥资1689.01万港元回购184.4万股
Zhi Tong Cai Jing· 2025-08-01 10:05
VITASOY INT'L(00325)发布公告,于2025年8月1日斥资1689.01万港元回购股份184.4万股,每股回购价 格为9.14-9.17港元。 ...
港股新消费持续走低,布鲁可跌近8%,泡泡玛特跌超4%
Mei Ri Jing Ji Xin Wen· 2025-07-31 06:19
Group 1 - The Hong Kong stock market for new consumption continues to decline, with Bruker falling nearly 8% and Pop Mart dropping over 4% [1]
港股新消费概念持续走低,老铺黄金(06181.HK)跌超9%,布鲁可(00325.HK)跌超7%,泡泡玛特(09992.HK)、名创优品(09896.HK)等跟跌。
news flash· 2025-07-31 06:14
Group 1 - The new consumption concept in the Hong Kong stock market continues to decline, with significant drops in stock prices for several companies [1] - Old Poo Gold (06181.HK) experienced a decline of over 9%, while Bruker (00325.HK) fell by more than 7% [1] - Other companies such as Pop Mart (09992.HK) and Miniso (09896.HK) also saw declines in their stock prices [1]
7月31日电,港股新消费持续走低,老铺黄金跌超9%,布鲁可跌近8%,泡泡玛特跌超4%。
news flash· 2025-07-31 06:14
智通财经7月31日电,港股新消费持续走低,老铺黄金跌超9%,布鲁可跌近8%,泡泡玛特跌超4%。 ...
布鲁可亮相2025宝可梦杭州大师赛 将持续深化与全球知名IP合作
Core Viewpoint - The article highlights Bruco's participation in the 2025 Pokémon Hangzhou Master Tournament, showcasing 16 Pokémon-themed products and engaging fans through interactive events and competitions [1][12]. Product Offering - Bruco presented 16 products from the Pokémon series, including the classic versions "Adventure's Prologue" and "New Encounters," appealing to a wide range of players and evoking nostalgia [2][4]. - The products feature a dual specification design ("S version + L version") to enhance user experience, with S versions offering cute scenes and L versions utilizing special PVC materials for better tactile feedback and playability [5]. Innovation and Development - Bruco has invested significantly in innovation, holding over 500 patents that support a diverse product matrix, including various themed versions like Starry, Classic, and Legendary [5]. - The company emphasizes user-driven innovation and has established a unique BFC community to encourage creativity through online and offline competitions [5][6]. Event Highlights - The BFC creations showcased at the tournament included immersive experiences for fans, with a focus on character representation and large scene construction [6][8]. - The BFC speed-building competition attracted a large number of participants, demonstrating the popularity and engagement of the Pokémon fan community [10]. Strategic Direction - Bruco's strategy emphasizes a "full demographic, full price range, global" approach, aiming to deepen collaborations with globally recognized IPs like Pokémon to provide diverse building products [12].
又一只潮玩黑马?花旗首次覆盖看好“中国版乐高”布鲁可,预测净利三年复合增长54%
Hua Er Jie Jian Wen· 2025-07-25 07:36
Core Viewpoint - Bloks Group Limited, known as the "Chinese version of LEGO," went public on the Hong Kong Stock Exchange on January 10, 2024, and has rapidly become the largest assembly character toy company in China and the third largest globally, driven by strong IP operation capabilities, cost-effective products, and an efficient supply chain [1][4]. Group 1: Company Overview - Founded in 2014, Bloks focuses on the design, research, and sales of assembly character toys, holding over 50 globally recognized IPs including Ultraman, Transformers, Marvel Heroes, and Naruto [1]. - Bloks has established a market leadership position in the assembly character toy sector since its strategic shift in 2022, particularly after acquiring licenses for Ultraman in 2021 and Transformers in 2022 [4]. Group 2: Financial Performance - According to Citigroup's report, Bloks is expected to achieve a compound annual growth rate (CAGR) of 54% in adjusted net profit and 52% in revenue from 2024 to 2027 [1]. - The company reported a net profit of RMB 74 million for 2023, with projections of RMB 582 million for 2024 and RMB 2.131 billion for 2027, indicating significant growth [2]. Group 3: Competitive Advantage - Bloks' competitive edge lies in its high cost-performance ratio, targeting children aged 6-16 with products priced between RMB 19.9 and RMB 79, significantly lower than competitors like Bandai, which targets adult fans with prices ranging from RMB 99 to RMB 1000 [4]. - The company holds a 30.3% market share in China's assembly character toy market and a 6.3% share globally, ranking first in China and third worldwide [5]. Group 4: IP Strategy - Bloks' business model is heavily reliant on its IP portfolio, with over 50 licensed IPs and two self-developed IPs [6]. - The company plans to diversify its IP strategy to reduce reliance on key IPs, with Ultraman and Transformers expected to contribute 49% and 20% of revenue in 2024, respectively [8][11]. Group 5: Product Development - Bloks employs a "standardized structure + customized appearance" model for product design, allowing for rapid iteration and innovation, with a product development cycle of 6-7 months compared to the industry average of 10-12 months [12]. - The company aims to launch 800-1000 SKUs by 2025, significantly increasing from 197 in 2023 and approximately 400 in 2024 [12]. Group 6: Market Expansion - Bloks plans to increase its sales points in China from 150,000 in 2024 to 250,000-300,000 in 2025, focusing on lower-tier cities [13]. - The company is also expanding its overseas presence, with expectations for international business to grow from 3% of revenue in 2024 to 10% in 2025, targeting regions such as Southeast Asia, North America, and the EU [15].
港股新消费概念股部分下跌,老铺黄金(06181.HK)跌超6%,古茗(01364.HK)、布鲁可(00325.HK)、巨子生物(02367.HK)跌超4%。
news flash· 2025-07-23 06:31
Group 1 - The new consumption concept stocks in the Hong Kong market experienced a decline, with notable drops in specific companies [1] - Old Poo Gold (06181.HK) fell over 6%, indicating significant market reaction [1] - Other companies such as Gu Ming (01364.HK), Bluco (00325.HK), and Juzi Bio (02367.HK) also saw declines exceeding 4% [1]
港股收盘(07.16) | 恒指收跌0.29% 科技股走势分化 创新药概念热度延续
智通财经网· 2025-07-16 08:50
Market Overview - Hong Kong stocks experienced a pullback after an initial rise, with the Hang Seng Index closing down 0.29% at 24,517.76 points and a total trading volume of 258.95 billion HKD [1] - The Hang Seng China Enterprises Index fell 0.18% to 8,861.39 points, while the Hang Seng Tech Index decreased by 0.24% to 5,418.4 points [1] - Shenwan Hongyuan remains optimistic about investment opportunities in Hong Kong and A-share markets, predicting that Hong Kong will play a crucial role in the restructuring of the global financial order [1] Blue Chip Performance - Anta Sports (02020) led blue-chip stocks, rising 2.28% to 91.85 HKD, contributing 4.55 points to the Hang Seng Index [2] - Other notable performers included Kuaishou-W (01024) up 2.13% and Trip.com Group-S (09961) up 1.59%, while Shenzhou International (02313) and Zhongsheng Holdings (00881) saw declines of 2.75% and 2.67%, respectively [2] Sector Highlights - Large tech stocks showed mixed results, with Kuaishou rising over 2% and Baidu nearly 1%, while Tencent fell 0.19% [3] - The humanoid robot sector is gaining traction, with Shengye rising nearly 15% following positive developments [3] - The innovative drug sector remains active, with Lijun Pharmaceutical rising 13% amid ongoing interest in new drug procurement [4][5] Innovative Drug Sector - The 11th batch of national drug procurement has started, focusing on mature "old drugs" while excluding innovative drugs [5] - Analysts believe that the current innovative drug market is driven by value reassessment, with domestic investors increasing their positions through Hong Kong Stock Connect [5] Stablecoin Activity - China San San Media (08087) surged 72.73% after announcing plans to apply for a stablecoin license in Hong Kong, which will officially take effect on August 1 [6] - The global regulatory framework for stablecoins is expected to lead to significant industry growth [6] New Consumption Trends - New consumption stocks showed varied performance, with Guoquan (02517) up 7.29% and Hu Shang Ayi (02589) up 1.99%, while Gu Ming (01364) fell 4.26% [7] - Guoquan expects a net profit of approximately 180 to 210 million RMB for the first half of 2025, representing a year-on-year increase of 111% to 146% [7] Notable Stock Movements - Weiyali (00854) saw a dramatic increase of 288.34% after resuming trading, reaching a peak of 33.2 HKD [8] - Chongqing Machinery (02722) rose 14.06% following news of NVIDIA resuming sales of its H20 chip in China [9] - Jiufang Zhitu Holdings (09636) increased by 10.06% as it plans to issue shares for strategic investments [10] - Quzhi Group (00917) fell 12.06% after announcing a share placement at a discount to its market price [11]